Cell BiologybioRxivPreprint
New therapeutic combination to enhance endocytosis of antibodies and nucleic-acid aptamers targeting EGFR in glioblastoma cells
Elisabete Cruz Da Silva, Charlène D’Ancona, Hélène Justiniano…·Laurence Choulier
This study shows that gefitinib enhances endocytosis of EGFR-targeting conjugates, improving ADC toxicity in glioblastoma cells.
2 citations